Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGang Chen, MD
About this trial
The goal of this observational study is to learn about the Psychological Distress in Malignant Tumor Patients about Effects on Treatment Adherence, Outcomes, and Quality of Life. The main question it aims to answer is:
Does Psychological Distress affect Malignant Tumor Patients' Effects on Treatment Adherence, Outcomes, and Quality of Life? Malignant Tumor Patients with or without Psychological Distress will answer GAD-7 and PHQ-9 and their Treatment Adherence, Outcomes, and Quality of Life be recorded for 3 years.
Eligibility criteria
Qualifiers
(1) Confirmed malignant tumors by imaging or pathology (such as hepatobiliary carcinoma, gastric cancer, breast cancer, lung cancer, etc.)
(2) Planning to receive or currently undergoing systemic treatment (such as surgery, chemotherapy, TACE, targeted therapy, etc.)
(3) Age ≥18 years old
(4) Sign the informed consent form and voluntarily participate in this study
Disqualifiers
(1) Combined with severe systemic diseases (such as severe cardiovascular and cerebrovascular diseases)
(2) There is severe cognitive impairment and it is impossible to complete the questionnaire assessment
(3) Incomplete clinical data or loss to follow-up
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Gang Chen, MD
Lead sponsor
First Affiliated Hospital of Wenzhou Medical University
Sponsor institution
Source ClinicalTrials.gov